Christel Vangestel

Wilrijk, VLG 2610, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Synthesis and Preclinical Evaluation of Druglike 18F-Labeled Fibroblast Activation Protein (FAP) Inhibitors with Enhanced Tumor Retention.

Synthesis and Preclinical Evaluation of Druglike 18F-Labeled Fibroblast Activation Protein (FAP) Inhibitors with Enhanced Tumor Retention.

Journal: Bioconjugate chemistry

Published: August 12, 2025

Development of caspase-3-selective activity-based probes for PET imaging of apoptosis.

Development of caspase-3-selective activity-based probes for PET imaging of apoptosis.

Journal: EJNMMI radiopharmacy and chemistry

Published: June 26, 2024

First-in-human study of a novel cell death tracer [99mTc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers.

First-in-human study of a novel cell death tracer [99mTc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers.

Journal: EJNMMI radiopharmacy and chemistry

Published: July 24, 2023

Site-specific 68Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models.

Site-specific 68Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models.

Journal: EJNMMI radiopharmacy and chemistry

Published: March 29, 2023

18F-FDG and 18F-FLT Uptake Profiles for Breast Cancer Cell Lines Treated with Targeted PI3K/Akt/mTOR Therapies.

18F-FDG and 18F-FLT Uptake Profiles for Breast Cancer Cell Lines Treated with Targeted PI3K/Akt/mTOR Therapies.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: December 06, 2022

Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments.

Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments.

Journal: Pharmaceutics

Published: March 10, 2022

ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma.

ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma.

Journal: Frontiers in oncology

Published: July 30, 2021

Immuno-PET Molecular Imaging of RANKL in Cancer.

Immuno-PET Molecular Imaging of RANKL in Cancer.

Journal: Cancers

Published: March 22, 2021

Early Changes in [18F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts.

Early Changes in [18F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts.

Journal: Molecular imaging

Published: February 08, 2021

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update.

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update.

Journal: Cancers

Published: June 08, 2020

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators.

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators.

Journal: EJNMMI radiopharmacy and chemistry

Published: June 02, 2020

Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.

Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.

Journal: Nuclear medicine and biology

Published: September 06, 2019

Showing 1-12 of 38

Last Updated: 09/26/2026